In simple terms, Hubei Biocause Pharmaceutical Co., Ltd. has 4940.629 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.698% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.006%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.007%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.002% return, is a testament to Hubei Biocause Pharmaceutical Co., Ltd.'s adeptness in optimizing resource deployment. Hubei Biocause Pharmaceutical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.028%. Furthermore, the proficiency of Hubei Biocause Pharmaceutical Co., Ltd. in capital utilization is underscored by a remarkable 0.002% return on capital employed.
Stock Prices
Hubei Biocause Pharmaceutical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.59, while its low point bottomed out at $2.48. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Hubei Biocause Pharmaceutical Co., Ltd.'s stock market.
Liquidity Ratios
Analyzing 000627.SZ liquidity ratios reveals its financial health of the firm.
The current ratio of 163.43% gauges short-term asset coverage for liabilities.
The quick ratio (-18.12%) assesses immediate liquidity, while the cash ratio (89.40%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
163.43%
Quick Ratio
-18.12%
Cash Ratio
89.40%
Profitability Ratios
000627.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -2.56% underscores its earnings before tax deductions.
The effective tax rate stands at 56.96%, revealing its tax efficiency.
The net income per EBT, 26.74%, and the EBT per EBIT, -444.35%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 0.58%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
-2.56%
Effective Tax Rate
56.96%
Net Income per EBT
26.74%
EBT per EBIT
-444.35%
EBIT per Revenue
0.58%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.63, it details the span from stock purchase to revenue.
Meanwhile, a 1 cash conversion cycle and -310.64% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
-18
Days of Inventory Outstanding
61
Operating Cycle
-56.37
Days of Payables Outstanding
76
Cash Conversion Cycle
-132
Receivables Turnover
-3.11
Payables Turnover
4.80
Inventory Turnover
5.97
Fixed Asset Turnover
58.35
Asset Turnover
0.30
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -2.44, and free cash flow per share, -2.45, depict cash generation on a per-share basis.
The cash per share value, 4.66, showcases liquidity position.
A payout ratio of -2.47 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, -0.14, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
-2.44
Free Cash Flow per Share
-2.45
Cash per Share
4.66
Payout Ratio
-2.47
Operating Cash Flow Sales Ratio
-0.14
Free Cash Flow to Operating Cash Flow Ratio
1.01
Cash Flow Coverage Ratio
-0.51
Short Term Coverage Ratio
-0.73
Capital Expenditure Coverage Ratio
-186.73
Dividend Paid and Capex Coverage Ratio
-8.06
Dividend Payout Ratio
0.10
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 8.44%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 1.16, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 25.96%, and total debt to capitalization, 53.66%, ratios shed light on its capital structure.
cards.indicator
cards.value
Debt Ratio
8.44%
Debt Equity Ratio
1.16
Long Term Debt to Capitalization
25.96%
Total Debt to Capitalization
53.66%
Cash Flow to Debt Ratio
-0.51
Company Equity Multiplier
13.72
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 10.06, provides a glimpse into top-line earnings distributed across each share.
Net income per share, -0.13, reflects the portion of profit attributed to each share.
The book value per share, 4.17, represents the net asset value distributed per share, while the tangible book value per share, 5.50, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
10.06
Net Income Per Share
-0.13
Book Value Per Share
4.17
Tangible Book Value Per Share
5.50
Shareholders Equity Per Share
4.17
Interest Debt Per Share
5.14
Capex Per Share
-0.01
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 0.22%, indicates top-line expansion, while the gross profit growth, -3.06%, reveals profitability trends.
EBIT growth, -96.10%, and operating income growth, -96.10%, offer insights into operational profitability progression.
The net income growth, -227.65%, showcases bottom-line expansion, and the EPS growth, -230.00%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
0.22%
Gross Profit Growth
-3.06%
EBIT Growth
-96.10%
Operating Income Growth
-96.10%
Net Income Growth
-227.65%
EPS Growth
-230.00%
EPS Diluted Growth
-230.00%
Dividends per Share Growth
102.03%
Operating Cash Flow Growth
26.71%
Free Cash Flow Growth
28.12%
10-Year Revenue Growth per Share
1300.41%
5-Year Revenue Growth per Share
59.76%
3-Year Revenue Growth per Share
14.11%
10-Year Operating CF Growth per Share
1891.06%
5-Year Operating CF Growth per Share
-36.71%
3-Year Operating CF Growth per Share
-55.49%
10-Year Net Income Growth per Share
-75.90%
5-Year Net Income Growth per Share
-148.86%
3-Year Net Income Growth per Share
-158.30%
10-Year Shareholders Equity Growth per Share
302.12%
5-Year Shareholders Equity Growth per Share
7.81%
3-Year Shareholders Equity Growth per Share
-2.58%
10-Year Dividend per Share Growth per Share
1165.16%
3-Year Dividend per Share Growth per Share
122.88%
Receivables Growth
100.00%
Inventory Growth
-60.66%
Asset Growth
4.62%
Book Value per Share Growth
-3.84%
Debt Growth
-9.44%
SGA Expenses Growth
428.52%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 11,148,426,306.65, captures the company's total value, considering both debt and equity.
Income quality, -7.44, assesses the reliability of reported earnings.
The ratio of intangibles to total assets, 2.14%, indicates the value of non-physical assets, and capex to operating cash flow, -0.71%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
11,148,426,306.65
Income Quality
-7.44
Sales General and Administrative to Revenue
0.04
Intangibles to Total Assets
2.14%
Capex to Operating Cash Flow
-0.71%
Capex to Revenue
-0.14%
Capex to Depreciation
-44.32%
Graham Number
3.52
Return on Tangible Assets
-0.22%
Graham Net Net
-47.82
Working Capital
26,203,833,479
Tangible Asset Value
27,158,013,476
Net Current Asset Value
-217,636,246,352
Invested Capital
1
Average Receivables
-14,226,790,104
Average Payables
577,971,916.5
Average Inventory
7,317,983,923.5
Days Payables Outstanding
35
Days of Inventory On Hand
153
ROIC
0.92%
ROE
-0.03%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.57, and the price to book ratio, 0.57, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 0.14, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, -0.97, and price to operating cash flows, -0.98, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
0.57
Price to Book Ratio
0.57
Price to Sales Ratio
0.14
Price Cash Flow Ratio
-0.98
Price Earnings to Growth Ratio
0.17
Enterprise Value Multiple
0.84
Price Fair Value
0.57
Price to Operating Cash Flow Ratio
-0.98
Price to Free Cash Flows Ratio
-0.97
Price to Tangible Book Ratio
0.67
Enterprise Value to Sales
0.22
Enterprise Value Over EBITDA
9.17
EV to Operating Cash Flow
1.17
Earnings Yield
-4.69%
Free Cash Flow Yield
68.19%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
